---
figid: PMC6388767__nihms-1007098-f0001
figlink: /pmc/articles/PMC6388767/figure/F1/
number: Figure 1
caption: Bromouridine sequencing (Bru-seq) of MI-503 treated Ewing sarcoma cells identifies
  the SSP as a key oncogenic target. (A) Gene ontology analysis, showing the top ten
  differentially regulated pathways after MI-503 treatment. (B) Diagram of the de
  novo serine biosynthesis and folate pathways, showing fold changes in expression
  after MI-503 treatment. Small arrows indicate that fold changes in gene expression
  were down after MI-503 treatment.
pmcid: PMC6388767
papertitle: Menin regulates the serine biosynthetic pathway in Ewing sarcoma.
reftext: Laurie K. Svoboda, et al. J Pathol. 2018 Jul;245(3):324-336.
pmc_ranked_result_index: '140889'
pathway_score: 0.7948783
filename: nihms-1007098-f0001.jpg
figtitle: Bromouridine sequencing (Bru-seq) of MI-503 treated Ewing sarcoma cells
  identifies the SSP as a key oncogenic target
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6388767__nihms-1007098-f0001.html
  '@type': Dataset
  description: Bromouridine sequencing (Bru-seq) of MI-503 treated Ewing sarcoma cells
    identifies the SSP as a key oncogenic target. (A) Gene ontology analysis, showing
    the top ten differentially regulated pathways after MI-503 treatment. (B) Diagram
    of the de novo serine biosynthesis and folate pathways, showing fold changes in
    expression after MI-503 treatment. Small arrows indicate that fold changes in
    gene expression were down after MI-503 treatment.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PHGDH
  - MTHFD2
  - PSPH
  - PSAT1
  - SHMT2
  - GJA1
  - 3-Phosphoglycerate
  - L-serine
  - isoprenoid
  - unsaturated fatty acid
  - fatty acid
  - amino acid
  - ethanol
  - cholesterol
  - NAD
  - NADH
  - 3-Phospho-hydroxypyruvate
  - 3-Phospho-serine
  - Serine
  - Glycine
  - methylene THF
  - NADP
  - NADPH
  - methenyl
genes:
- word: PHGDH
  symbol: PHGDH
  source: hgnc_symbol
  hgnc_symbol: PHGDH
  entrez: '26227'
- word: MTHFD2
  symbol: MTHFD2
  source: hgnc_symbol
  hgnc_symbol: MTHFD2
  entrez: '10797'
- word: PSPH
  symbol: PSPH
  source: hgnc_symbol
  hgnc_symbol: PSPH
  entrez: '5723'
- word: PSAT1
  symbol: PSAT1
  source: hgnc_symbol
  hgnc_symbol: PSAT1
  entrez: '29968'
- word: SHMT2
  symbol: SHMT2
  source: hgnc_symbol
  hgnc_symbol: SHMT2
  entrez: '6472'
- word: Odds
  symbol: ODD
  source: hgnc_alias_symbol
  hgnc_symbol: GJA1
  entrez: '2697'
chemicals:
- word: 3-Phosphoglycerate
  source: MESH
  identifier: C005156
- word: L-serine
  source: MESH
  identifier: C047902
- word: isoprenoid
  source: MESH
  identifier: D013729
- word: unsaturated fatty acid
  source: MESH
  identifier: D005231
- word: fatty acid
  source: MESH
  identifier: D005227
- word: amino acid
  source: MESH
  identifier: D000596
- word: ethanol
  source: MESH
  identifier: D000431
- word: cholesterol
  source: MESH
  identifier: D002784
- word: NAD
  source: MESH
  identifier: D009243
- word: NADH
  source: MESH
  identifier: D009243
- word: 3-Phospho-hydroxypyruvate
  source: MESH
  identifier: C012375
- word: 3-Phospho-serine
  source: MESH
  identifier: C407063
- word: Serine
  source: MESH
  identifier: C047902
- word: Glycine
  source: MESH
  identifier: D005998
- word: methylene THF
  source: MESH
  identifier: C006461
- word: NADP
  source: MESH
  identifier: D009249
- word: NADPH
  source: MESH
  identifier: D009249
- word: methenyl
  source: MESH
  identifier: C018092
diseases: []
---
